Cannabis Based Pain Relief Solution Receives European Patent Approval
Portfolio Pulse from Jelena Martinovic
IGC Pharma, Inc. (NYSE:IGC) has been granted a European Patent for its cannabis-based pain relief solution. The patented method uses a cream base infused with a unique blend of cannabinoids for transdermal absorption, providing pain relief without adverse side effects. The company's CEO, Ram Mukunda, believes this innovative approach has the potential to disrupt the industry and provide investors with a unique opportunity.
October 20, 2023 | 9:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IGC Pharma's new patent for a cannabis-based pain relief solution could potentially disrupt the pain management industry and provide a unique investment opportunity.
The granting of the European Patent for IGC Pharma's cannabis-based pain relief solution could potentially disrupt the pain management industry. This could lead to increased interest in the company and its stock, potentially driving up the price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100